Ishmeet Kaur – Unveiling the Future of Biotechnology: Meet the Innovator Behind Groundbreaking Research

Summary:

Name: Ishmeet Kaur
Location: Gurdaspur, Punjab, India

Objective:
To utilize my expertise in biotechnology and analytical skills to deliver impactful research insights, driving innovation and supporting organizational growth.

Education:

M.Tech. Biotechnology
BOARD: UGC Approved
SCHOOL/UNIVERSITY: Thapar Institute of Engineering and Technology, Patiala
YEAR: 2022-24
CGPA: 9.45

B.Tech. Biotechnology
BOARD: UGC Approved
SCHOOL/UNIVERSITY: Beant College of Engineering and Technology, Gurdaspur
YEAR: 2018-22
CGPA: 8.31

12th (MEDICAL)
BOARD: CBSE
SCHOOL: TC International School, Gurdaspur
YEAR: 2016-18
%AGE: 76%

10th
BOARD: CBSE
SCHOOL: Trinity Public School, Gurdaspur
YEAR: 2016
%AGE: 9.6

Professional Training and Experience:

1) Research Project
Institute: Thapar Institute of Engineering and Technology (1-8-2023 to 7-8-2024)
Key Objectives:
– Studied SNP variants of the hTERT gene.
– Evaluated the role of polymorphic variants in lung cancer.
– Assessed clinical outcomes and toxicity profiles of patients undergoing platinum-based chemotherapy.
– Analyzed overall survival and clinicopathological features.

2) Industrial Training
Quality Control Intern | Morepen Laboratories, Parwanoo, Himachal Pradesh (21-6-2021 to 4-8-2021)
– Gained practical knowledge of quality control methodologies specific to API production.
– Developed expertise in quality assurance protocols, instrumentation, and documentation practices.

3) Certified Course
Hands-on workshop on Drug Designing | Hazra Lab (2022)

Extra Curriculars and Skills:

Literary Society: Student Coordinator (2019), Event Manager (2020), President (2021)
Biogen Society: Executive Member (2020), Senior Executive (2021)
– Anchored college fest stages, organized debates, and coordinated events, enhancing communication, leadership, teamwork, creativity, and planning skills.

Publication:

Kaur, I., Kansal, H., Singh, S., Singh, N., & Sharma, S. (2024). Association of hTERT MNS16A polymorphism with clinical outcomes of North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Clinical and Translational Oncology. Link

Hobbies:

Journaling & Reflective Writing, DIY Beauty & Wellness Treatments, Dancing, Craftwork & DIY Projects, Traveling & Exploring New Cultures

References:

Dr. Siddharth Sharma, Professor, Department of Biotechnology, Thapar Institute of Engineering and Technology.
Email: [Email Hidden] | Phone: [Phone Hidden]

“`

Cover Letter:

Of course, please provide the data that needs to be redacted.